Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CardieX ( (AU:CDX) ) has issued an update.
Cardiex Limited announced the results of its Extraordinary General Meeting held on September 17, 2025, where all proposed resolutions were passed. This outcome supports the company’s strategic initiatives, including share placements and long-term incentives for directors and employees, potentially strengthening its market position and stakeholder confidence.
More about CardieX
Cardiex is a company focused on advancing medical technology for vascular health, offering products such as medical and home health devices and digital solutions for conditions like hypertension and cardiovascular disease. Their products are based on the SphygmoCor® vascular biomarker technology, and the company is listed on the Australian Stock Exchange (ASX: CDX).
Average Trading Volume: 469,043
Technical Sentiment Signal: Sell
Current Market Cap: A$15.95M
For detailed information about CDX stock, go to TipRanks’ Stock Analysis page.